
R42 Group
North America, California, United States, Stanford
Description
R42 Group actively invents and finances deep science ventures.
Investor Profile
R42 Group has made 25 investments, with 4 in the past 12 months and 20% as lead.
Stage Focus
- Seed (56%)
- Series A (16%)
- Pre Seed (12%)
- Series Unknown (8%)
- Series C (4%)
- Convertible Note (4%)
Country Focus
- United Kingdom (64%)
- United States (28%)
- Switzerland (8%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Life Science
- Medical
- Pharmaceutical
- Software
- Information Technology
- Biopharma
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.